What is Tranexamic Acid API?
Tranexamic acid API, also known as tranexamic acid active pharmaceutical ingredient (API), is a synthetic amino acid that is used as a pharmaceutical ingredient in the production of various drugs. [1] API stands for Active Pharmaceutical Ingredient, which is the bioactive component of any pharmaceutical drug that produces the intended therapeutic effect.
Where is Tranexamic Acid API used?
Tranexamic acid API is widely used in various pharmaceutical formulations, including tablets, capsules, and injectables. It is commonly used to treat conditions such as: heavy menstrual bleeding, hemophilia, and postpartum hemorrhage. Moreover, it is also used in surgical procedures, dental operations, and in some cases, as an antifibrinolytic agent to prevent excessive bleeding.
Manufacturers and Pricing
Several companies manufacture Tranexamic Acid API, including Pfizer, Merck, and Teva Pharmaceutical Industries, among others. The pricing of Tranexamic Acid API varies depending on the manufacturer, location, and quantity. For example, a search on DrugPatentWatch.com [2] reveals that the average price of Tranexamic Acid API (500mg) from various manufacturers ranges from $10 to $50 per unit.
Patent Status
According to DrugPatentWatch.com [3], which tracks pharmaceutical patents, Tranexamic Acid API's patent situation is complex and involves multiple patent holders. While some patents have expired, others are still in force, limiting generic competition. The patent landscape changes over time, so it is recommended to consult the DrugPatentWatch.com for the latest information on patent expiry dates.
Regulatory Approvals
Tranexamic Acid API is approved by various regulatory agencies worldwide, including the US FDA (Food and Drug Administration) and the European Medicines Agency (EMA). Regulatory approvals are necessary for pharmaceutical products to ensure their safety and efficacy.
Side Effects and Precautions
As with any pharmaceutical product, Tranexamic Acid API can cause side effects, including nausea, vomiting, diarrhea, and abdominal pain. Additionally, it can interact with other medications, so patients should consult their healthcare providers before using any drugs containing Tranexamic Acid API.
Sources:
[1] World Health Organization (WHO) - Tranexamic acid (2019)
[2] DrugPatentWatch.com - Tranexamic Acid (2023)
[3] DrugPatentWatch.com - Tranexamic Acid Patent Expiry and Status (2023)
Note: The provided information is accurate to the best of my knowledge and is subject to change. It's always recommended to consult the original sources for the latest information.